Novel Coronavirus (SARS-CoV-2/COVID-19)

The Department of Health and Human Services’ Administration for Strategic Preparedness and Response yesterday awarded $600 million for 12 domestic COVID-19 test manufacturers to expand capacity.
AHA is providing its latest social media toolkit to help hospitals encourage vaccination against COVID-19.
Under the Department of Health and Human Services’ recent agreement with Regeneron to develop a new monoclonal antibody to prevent COVID-19, the U.S. list price for a new commercialized product could not exceed the retail price in comparable markets globally, HHS said.
In time for back-to-school health screenings, AHA Aug. 25 released an infographic on strategies that clinicians and the Centers for Disease Control and Prevention have employed to encourage COVID-19 vaccinations among children.
With fall approaching, health officials across the country are once again bracing for a rise in respiratory illnesses, including the triple threat of COVID-19, flu and RSV.
This third look book from the AHA Living Learning Network, a virtual community focused on transforming health care, spotlights how hospital and health systems are innovating and partnering to advance health care quality and equity and bolster the health care workforce as they emerge from the COVID-…
Ensuring a robust nursing workforce in rural Ohio poses unique challenges. Armed with a broad plan to retain their current workforce and recruit additional team members, the team at Fisher-Titus Health created a plan to recruit international nurses to their community ensure they remain a strong…
Vaccines are powerful weapons against most diseases. Nearly a dozen serious diseases —including polio, smallpox and whooping cough — have been eradicated because of vaccines. That’s important to remember as we observe National Immunization Awareness Month in August.
The National Institutes of Health’s Researching COVID to Enhance Recovery (RECOVER) Initiative opened enrollment for clinical trials to evaluate the safety and effectiveness of at least four potential treatments for long COVID in adults.
A recent JAMA-published study on U.S. hospitals’ financial performance during the COVID-19 public health emergency suffers from several methodological setbacks that undermine its credibility, writes Aaron Wesolowski, AHA’s vice president of policy, research, analytics and strategy.